PRMT5 and cancer: These results suggest that the complex with PRMT5 and MEP50 in the cytoplasm plays an important role in cancer development and that the inhibition of PRMT5/MEP50 activity exhibits anti-tumour effects regarding cancer vulnerability only in NDRG2low cancer cells.